Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor
Mm. Mueller et al., Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor, AM J PATH, 159(4), 2001, pp. 1567-1579
Citations number
80
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Tumor microenvironment is crucial for cancer growth and progression as evid
enced by reports on the significance of tumor angiogenesis and stromal cell
s. Using the HaCaT/HaCaT-ras human skin carcinogenesis model, we studied tu
mor progression from benign tumors to highly malignant squamous cell carcin
omas. Progression of tumorigenic HaCaT-ras clones to more aggressive and ev
entually metastatic phenotypes was reproducibly achieved by their in vivo g
rowth as subcutaneous tumors in nude mice. Their enhanced malignant phenoty
pe was stably maintained in recultured tumor cells that represented, identi
fied by chromosomal analysis, a distinct subpopulation of the parental line
. Additional mutagenic effects were apparent in genetic alterations involvi
ng chromosomes 11 and 2, and in amplification and overexpression of the H-r
as oncogene. Importantly, in vitro clonal. selection of benign and malignan
t cell lines never resulted in late-stage malignant clones, indicating the
importance of the in vivo environment in promoting an enhanced malignant ph
enotype. Independently of their H-ras status, all in vivo-progressed tumor
cell lines (five of five) exhibited a constitutive and stable expression of
the hematopoietic growth factors granulocyte colony-stimulating factor and
granulocyte-macrophage colony-stimulating factor, which may function as au
tocrine/paracrine mediators of tumor progression in vivo. Thus, malignant p
rogression favored by the in vivo microenvironment requires both clonal sel
ection of subpopulations. adapted to in vivo growth and mutational events l
eading to stable functional alterations.